MAPT and Alzheimer disease: Besides the poor diagnostic accuracy of tau in the discrimination of AD from VaD, the observation of higher tau levels, but not of 14-3-3 and NSE in AD compared to VaD would suggest that, a specific AD mechanism, rather than axonal damage, contributes to elevated CSF tau in AD.